Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
06/05/2014 | WO2014083003A1 Pro-cognitive compound |
06/05/2014 | US20140155680 Angiogenesis initiation and growth |
06/05/2014 | US20140155678 Focused radiation for augmenting immune-based therapies against neoplasms |
06/05/2014 | US20140155477 Substituted biaryl sulfonamides and the use thereof |
06/05/2014 | US20140155461 Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases |
06/05/2014 | US20140155456 Use of the phytocannabinoid cannabidiol (cbd) in combination with a standard anti-epileptic drug (saed) in the treatment of epilepsy |
06/05/2014 | US20140155444 Tetrahydronaphthalene derivatives |
06/05/2014 | US20140155442 Anti-obesity agent comprising high-purity epa |
06/05/2014 | US20140155433 Biaryl derivatives as nachr modulators |
06/05/2014 | US20140155431 Modulators of atp-binding cassette transporters |
06/05/2014 | US20140155409 Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance |
06/05/2014 | US20140155404 Piperazinylpiperidine derivatives as chemokine receptor antagonists |
06/05/2014 | US20140155401 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands |
06/05/2014 | US20140155393 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
06/05/2014 | US20140155384 Compounds and methods of treating diabetes |
06/05/2014 | US20140155382 Anti-viral compounds |
06/05/2014 | US20140155367 Compounds and compositions for the treatment of parasitic diseases |
06/05/2014 | US20140155361 Method for treating lung disease |
06/05/2014 | US20140155358 Therapeutic Compounds |
06/05/2014 | US20140155346 Cosmetic and/or dermatological use of oligosaccharide compounds for preventing and treating stretch marks |
06/05/2014 | US20140155338 Use of pde iii inhibitors for the reduction of heart size in mammals suffering from heart failure |
06/05/2014 | US20140155326 Egfr and c-met fibronectin type iii domain binding molecules |
06/05/2014 | US20140155325 Egfr and c-met fibronectin type iii domain binding molecules |
06/05/2014 | US20140155322 Method of Preventing Or Reducing Scarring Of Human Skin |
06/05/2014 | US20140155316 Fibroblast growth factor 1 protein fragments and methods of use |
06/05/2014 | US20140155315 Synthetic linear apelin mimetics for the treatment of heart failure |
06/05/2014 | US20140154340 Methods to treat cancer using cyclosporine and cyclosporine derivatives |
06/05/2014 | US20140154339 Fast Acting Inhibitor of Gastric Acid Secretion |
06/05/2014 | US20140154335 Antimicrobial packaing |
06/05/2014 | US20140154320 Extended-release formulation for reducing the frequency of urination and method of use thereof |
06/05/2014 | US20140154312 Oral targetted drug delivery system |
06/05/2014 | US20140154307 Inhibition of factor b, the alternative complement pathway and methods related thereto |
06/05/2014 | US20140154272 Compound and method for modulating opioid receptor activity |
06/05/2014 | US20140154261 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
06/05/2014 | US20140154246 Cai-based systems and methods for the localized treatment of ocular and other diseases |
06/05/2014 | US20140154244 Methods of Treating Primary Brain Tumors by Administering Letrozole |
06/05/2014 | US20140154243 Specific binding agents to hepatocyte growth factor |
06/05/2014 | US20140154240 Pyrazolo[1,5-a]pyrimidines for antiviral treatment |
06/05/2014 | US20140154232 Use of Pl3K Inhibitors for the Treatment of Obesity, Steatosis and Ageing |
06/05/2014 | US20140154229 Proteolytic extract from bromelain for the treatment of connective tissue disorders |
06/05/2014 | US20140154226 Regeneration and repair of neural tissue using postpartum-derived cells |
06/05/2014 | US20140154214 Selective glucagon-like-peptide-2 (glp-2) analogues |
06/05/2014 | US20140154211 2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
06/05/2014 | US20140154210 Solid Forms of a Thiophosphoramidate Nucleotide Prodrug |
06/05/2014 | US20140154208 Novel [N-Me-4-hydroxyleucine]-9-Cyclosporin Analogues for Treatment and Prevention of Hepatitis C Infection |
06/05/2014 | DE112012002813T5 Kombinationsbehandlung (zB mit ABT-072 oder ABT-333 von DAAs zur Verwendung in der Behandlung von HCV) Combination treatment (eg with ABT-072 or ABT-333 of DAAs for use in the treatment of HCV) |
06/04/2014 | EP2737908A1 Viscoelastic gels in ophthalmic surgery |
06/04/2014 | EP2737904A2 Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury |
06/04/2014 | EP2737902A1 Compositions comprising cimetidine and n,o-carboxymethyl chitosan for the prevention and therapy of pathologies of the skin and the mucous membranes and in the odontostomatological field |
06/04/2014 | EP2737900A1 Ndm inhibitor |
06/04/2014 | EP2737898A1 Compositions comprising Tramadol and Celecoxib in the treatment of pain |
06/04/2014 | EP2736508A1 Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor |
06/04/2014 | EP2736501A1 Intrathecal or epidural administration of 3-[(1s,2s)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol |
06/04/2014 | EP2736491A2 Bepotastine compositions |
06/04/2014 | CN103841969A Treatment and prevention of diseases mediated by microorganisms via drug-mediated manipulation of the eicosanoid balance |
06/04/2014 | CN103830733A Non-invasive green immune self-healing eliminating method for carcinoma lump |
06/04/2014 | CN103830732A Method for treating peritoneal fibrosis |
06/04/2014 | CN103830731A Glucocorticoid/H1 receptor antagonist compound inhalation composition |
06/04/2014 | CN103830730A Budesonide/H1 receptor antagonist compound inhalant |
06/04/2014 | CN103830729A Fluticasone and fluticasone ester/H1 receptor antagonist inhalant |
06/04/2014 | CN103830728A Compound inhalation medicine of ciclesonide and H1 receptor antagonist |
06/04/2014 | CN103830727A Compound inhalation medicine of mometasone furoate and H1 receptor antagonist |
06/04/2014 | CN103830726A Antimicrobial organic nanometer composition and preparation method thereof |
06/04/2014 | CN103830238A Application of five-membered benzoazacyclopiperidine derivative |
06/04/2014 | CN103830208A H1-receptor-antagonist-containing inhalation preparation |
06/04/2014 | CN102698116B Application of lophatherum gracile total flavonoids in preparation of medicine and functional food for preventing and treating myocardial ischemia disease |
06/04/2014 | CN102676516B New use of microRNA 145 |
06/04/2014 | CN102552910B Application of extracellular matrix protein 1 and regulator thereof in preparing medicament for diagnosing or treating allergic diseases |
06/04/2014 | CN102026661B Nutrient composition capable of adjusting energy amount, water amount and salt equivalent |
06/04/2014 | CN101780080B Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
06/04/2014 | CN101708338B Prodrug containing sterides structures and high dispersion preparation thereof |
06/03/2014 | US8741970 Composition and method for the enhancement of the efficacy of drugs |
06/03/2014 | US8741943 Bicyclic compound, production and use thereof |
06/03/2014 | US8741905 Compounds and methods for treating autoimmune diseases |
06/03/2014 | US8741880 Antiglucocorticoid therapy for the prevention of neurological damage in premature infants |
06/03/2014 | US8741876 Therapeutic agent for ulcerative colitis |
06/03/2014 | US8741869 Oligodeoxynucleotide and its use to induce an immune response |
06/03/2014 | US8741351 Microspheres for active embolization |
06/03/2014 | US8741313 Polypeptide vaccine and vaccination strategy against mycobacterium |
06/03/2014 | CA2633356C Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same |
06/03/2014 | CA2486716C Compositions and their uses for alleviating pain |
06/03/2014 | CA2443995C Endothelial cell expression patterns |
06/03/2014 | CA2434490C Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions |
06/03/2014 | CA2412764C Stimulation of cellular regeneration and differentiation in the inner ear |
06/03/2014 | CA2395892C Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
06/02/2014 | DE202014000996U1 Inhibitoren des microRNA-Argonaute Protein-Komplexes Inhibitors of microRNA-Argonaute protein complex |
05/30/2014 | WO2014081944A2 Egfr and c-met-fibronectin type iii domain binding molecules |
05/30/2014 | WO2014081029A1 Prophylactic, therapeutic or alleviating agent for peripheral nerve disorders caused by anti-cancer agents |
05/30/2014 | WO2014080162A1 Vip and an alpha-adrenergic blocker for use in the diagnosis of erectile dysfunction and vascular ischaemia |
05/30/2014 | WO2014080161A1 Vip and an alpha-adrenergic blocker for use in the treatment of erectile dysfunction post radical prostatectomy |
05/30/2014 | WO2014079709A1 Use of small molecule inhibitors/activators in combination with (deoxy)nucleoside or (deoxy)nucleotide analogs for treatment of cancer and hematological malignancies or viral infections |
05/30/2014 | WO2014047569A9 Product comprising a nicotine-containing material and an anti-cancer agent |
05/29/2014 | US20140148513 Small molecule therapeutic compounds targeting thioesterase deficiency disorders and methods of using the same |
05/29/2014 | US20140148499 Methods and reagents for efficient control of hiv progression |
05/29/2014 | US20140148494 Spiro-oxindole mdm2 antagonists |
05/29/2014 | US20140148478 Heteroquinoline-3-carboxamides as kcnq2/3 modulators |
05/29/2014 | US20140148476 Methods for treating obesity and disorders associated with hyperlipidemia in a mammal |
05/29/2014 | US20140148473 Use of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione in treatment of immune-related and inflammatory diseases |
05/29/2014 | US20140148462 Indanyloxydihydrobenzofuranylacetic acids |
05/29/2014 | US20140148459 Matrix metalloproteinase inhibitors |